Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Coherus BioSciences
Coherus BioSciences
(CHRS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Loqtorzi
Toripalimab
2023-10-27
Nasopharyngeal carcinoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegfilgrastim
healthy volunteers/patients
,
humoral immunity
,
therapeutic equivalency
,
neutropenia
,
neoplasms
,
fever
,
febrile neutropenia
,
hyperthermia
Toripalimab
renal cell carcinoma
,
squamous cell carcinoma of head and neck
,
neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
recurrence
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
Transplatin
recurrence
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
Albumin
neoplasms
Zimberelimab
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Cilmostim
ovarian neoplasms
,
ovarian epithelial carcinoma
Aglatimagene besadenovec
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Regramostim
ovarian neoplasms
,
ovarian epithelial carcinoma
Molgramostim
ovarian neoplasms
,
ovarian epithelial carcinoma
ETRUMADENANT
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Sodium lactate
neoplasms
Microcrystalline cellulose
neoplasms
Mk3475
neoplasms
,
renal cell carcinoma
,
carcinoma
,
non-small-cell lung carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Sagramostim
ovarian neoplasms
,
ovarian epithelial carcinoma
Montanide
ovarian neoplasms
,
ovarian epithelial carcinoma
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use